Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
European Journal of Cancer. Part B, Oral Oncology|July 1, 1995
Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11S Sonis, A Muska, J O'Brien, et al.British Dental Journal|January 23, 2016
Guidelines on prophylaxis to prevent infective endocarditisM H Thornhill, M Dayer, P B Lockhart, et al.British Dental Journal|August 13, 2016
A change in the NICE guidelines on antibiotic prophylaxisM H Thornhill, M Dayer, P B Lockhart, et al.British Journal of Cancer|September 1, 1977
Assessment of drug sensitivity of human leukaemic myeloblasts. I. Labelling human myeloblasts with 125IUdR for survival studies in miceR P Falcão, S Sonis, I C MacLennan, et al.Oral Oncology|August 22, 2006
Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancersS Sonis, R Haddad, M Posner, et al.Oral Surgery, Oral Medicine, and Oral Pathology|February 1, 1986
Oral complications of multimodality therapy for advanced squamous cell carcinoma of head and neckD Archibald, P B Lockhart, S T Sonis, et al.Bone Marrow Transplantation|February 8, 2005
Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantationP B Lockhart, M T Brennan, M L Kent, et al.Oral Diseases|January 3, 2013
Prevalence of oral lesions of autoimmune etiology in patients with primary Sjogren's syndromeK Likar-Manookin, C Stewart, I Al-Hashimi, et al.Journal of Oral Microbiology|March 23, 2017
<i>Porphyromonas gingivalis</i> is the most abundant species detected in coronary and femoral arteriesJ-L C Mougeot, C B Stevens, B J Paster, et al.Oral Diseases|February 6, 2009
The oral mucosa as a therapeutic target for xerostomiaW R Thelin, M T Brennan, P B Lockhart, et al.Pageof 6